BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32770675)

  • 1. Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas.
    Ota R; Sawada T; Tsuyama S; Sasaki Y; Suzuki H; Kaizaki Y; Hasatani K; Yamamoto E; Nakanishi H; Inagaki S; Tsuji S; Yoshida N; Doyama H; Minato H; Nakamura K; Kasashima S; Kubota E; Kataoka H; Tokino T; Yao T; Minamoto T
    J Pathol; 2020 Nov; 252(3):330-342. PubMed ID: 32770675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.
    Niwa A; Kuwano S; Tomita H; Kimura K; Orihara Y; Kanayama T; Noguchi K; Hisamatsu K; Nakashima T; Hatano Y; Hirata A; Miyazaki T; Kaneko K; Tanaka T; Hara A
    Oncotarget; 2017 Jun; 8(25):41078-41090. PubMed ID: 28467793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum.
    Ishizu K; Hashimoto T; Naka T; Yatabe Y; Kojima M; Kuwata T; Nonaka S; Oda I; Esaki M; Kudo M; Gotohda N; Yoshida T; Yoshikawa T; Sekine S
    J Gastroenterol; 2021 Nov; 56(11):988-998. PubMed ID: 34514550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
    Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
    J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal Neoplasms of Gastric Phenotype: An Immunohistochemical and Genetic Study With a Practical Approach to the Classification.
    Hida R; Yamamoto H; Hirahashi M; Kumagai R; Nishiyama K; Gi T; Esaki M; Kitazono T; Oda Y
    Am J Surg Pathol; 2017 Mar; 41(3):343-353. PubMed ID: 27984236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of marker genes and pathways specific to precancerous duodenal adenomas and early stage adenocarcinomas.
    Sakaguchi Y; Yamamichi N; Tomida S; Takeuchi C; Kageyama-Yahara N; Takahashi Y; Shiogama K; Inada KI; Ichinose M; Fujishiro M; Koike K
    J Gastroenterol; 2019 Feb; 54(2):131-140. PubMed ID: 29951927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.
    Kojima Y; Ohtsuka K; Ohnishi H; Abe N; Furuse J; Watanabe T; Sugiyama M
    Surg Today; 2018 Aug; 48(8):765-772. PubMed ID: 29525853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas.
    Sun L; Guzzetta AA; Fu T; Chen J; Jeschke J; Kwak R; Vatapalli R; Baylin SB; Iacobuzio-Donahue CA; Wolfgang CL; Ahuja N
    Epigenetics; 2014 May; 9(5):738-46. PubMed ID: 24518818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
    Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
    J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
    Wagner PL; Chen YT; Yantiss RK
    Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.
    Lee JH; Abraham SC; Kim HS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Rashid A; Hamilton SR; Wu TT
    Am J Pathol; 2002 Aug; 161(2):611-8. PubMed ID: 12163385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.
    Lee JH; Park SJ; Abraham SC; Seo JS; Nam JH; Choi C; Juhng SW; Rashid A; Hamilton SR; Wu TT
    Oncogene; 2004 Jun; 23(26):4646-54. PubMed ID: 15064707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.
    Tricarico R; Madzo J; Scher G; Cohen M; Jelinek J; Maegawa S; Nagarathinam R; Scher C; Chang WC; Nicolas E; Slifker M; Zhou Y; Devarajan K; Cai KQ; Kwok T; Nakajima P; Xu J; Mancuso P; Doneddu V; Bagella L; Williams R; Balachandran S; Maskalenko N; Campbell K; Ma X; Cañadas I; Viana-Errasti J; Moreno V; Valle L; Grivennikov S; Peshkova I; Kurilenko N; Mazitova A; Koltsova E; Lee H; Walsh M; Duttweiler R; Whetstine JR; Yen TJ; Issa JP; Bellacosa A
    Gastroenterology; 2023 May; 164(6):921-936.e1. PubMed ID: 36764492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
    Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
    Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas.
    Setia N; Wanjari P; Yassan L; Niu N; Kadri S; Ritterhouse L; Misdraji J; Brown I; Segal J; Hart J
    Hum Pathol; 2020 Mar; 97():103-111. PubMed ID: 31783043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis.
    Toyooka M; Konishi M; Kikuchi-Yanoshita R; Iwama T; Miyaki M
    Cancer Res; 1995 Jul; 55(14):3165-70. PubMed ID: 7606737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features.
    Watari J; Mitani S; Ito C; Tozawa K; Tomita T; Oshima T; Fukui H; Kadowaki S; Natsume S; Senda Y; Tajika M; Hara K; Yatabe Y; Shimizu Y; Muro K; Morimoto T; Hirota S; Das KM; Miwa H
    Sci Rep; 2019 Jul; 9(1):10526. PubMed ID: 31324814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum.
    Nakanishi H; Sawada T; Kaizaki Y; Ota R; Suzuki H; Yamamoto E; Aoki H; Eizuka M; Hasatani K; Takahashi N; Inagaki S; Ebi M; Kato H; Kubota E; Kataoka H; Takahashi S; Tokino T; Minamoto T; Sugai T; Sasaki Y
    PLoS One; 2020; 15(2):e0229262. PubMed ID: 32092099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.